Dried Blood Spot Collection Cards Market Size, Share, Growth Report 2022-2030

The global dried blood spot collection cards market size was valued at USD 350.6 million in 2021 and it is predicted to hit around USD 517.83 million by 2030 with a CAGR of 4.43% from 2022 to 2030.

Report Highlights

• The New Born Screening (NBS) segment dominated the market with a revenue share of over 20.3% in 2021. 
• Whatman 903 held the largest revenue share of over 30.4% in 2021.
• North America dominated the market and held a revenue share of over 35.06% in 2021. The region is likely to continue a similar trend over the projected period. 
• The Asia Pacific market is expected to register the fastest CAGR of 5.09% during the projected period. 

Immediate Delivery Available | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39702

Dried blood spot (DBS) collection cards are used to diagnose infectious diseases, particularly in resource-constrained areas, or to screen newborns for inherited metabolic problems, with a range of novel and innovative DBS uses only lately emerging.

Growing research studies for DBS testing and its advantages for diagnostic purposes are expected to fuel the market growth during the forecast period. In addition, the WHO recently recommended dried blood spot collection cards for diagnosis of HIV and hepatitis B & C due to the benefits of DBS in collecting blood and transport.

Moreover, dried blood spot collection cards have been used in a variety of toxicology applications, including toxicokinetics, epidemiological, environmental, and forensic toxicology. Dried blood spot collection cards are anticipated to be used as a sample preparation approach in forensic toxicology, and they can cost-effectively retain evidence for closed cases. Screening procedures as well as follow-up of markers of clinical or forensic interest are further toxicological applications where these cards may be progressively utilized.

Developing economies in Africa and Asia have the highest prevalence of rabies. The detection and surveillance of such diseases are hampered by the absence of clinical laboratories. Through dried blood spot collection cards, rabies can be diagnosed with limited resources. As per the data published by the Australian Trade and Investment Commission, Australia has become home to a thriving network of more than 470 biotechnology companies. A high number of established biotechnology and pharmaceutical players and extensive R&D initiatives being undertaken by them are expected to create a high need for DBS testing for therapeutic drug monitoring applications.

Various international organizations such as the U.S. Food and Drug Administration and the World Health Organization acknowledge the role of DBS cards in this pandemic. For instance, In June 2021, Symbiotic, Inc. was granted EUA by the FDA for a COVID-19 self-collect antibody test. This test can be conducted using ELISA with DBS for detecting COVID-19 antibodies in individuals aged 18 years and older, with collecting the sample in children aged 5 years and older by an adult.

The increase in the adoption of dried blood spot collection cards for therapeutic drug monitoring is a major factor expected to boost market growth in the near future. For instance, in July 2022, a study was conducted by researchers from the University of Washington and Med Biotech Laboratories to assess the feasibility of at-home dried blood spot collection along with PCR as a technique for malaria research. The study is anticipated to impact the therapeutic drug and vaccine studies for malaria. Researchers concluded that at-home dried blood spot collection cards for PCR are acceptable, robust, and feasible techniques.

On the other hand, it has been observed that dried blood spot collection cards are susceptible to cross-contamination or contamination by users, the environment, the equipment, and other collection cards during sample processing. The majority of these concerns can be mitigated by proper care and handling. Prolonged air drying of the conventional dried blood spot collection cards and contamination between samples during blood collection are some major causes of a high proportion of reactive samples.

Scope of The Report

Key Market Trends

Dried blood spot collection cards in newborn screening are estimated to witness healthy growth in the future

Dried blood spot (DBS) collection cards in newborn screening are estimated to witness healthy growth in the future attributed to an increasing number of newborn babies and growing demand for newborn screening. As per UNICEF, in 2018 around 2.5 million babies died in the first month of life due to lack of proper screening. Thus, due to surge in the demand for screening and to prevent these deaths in the future, there is a need for proper screening. DBS is widely used for screening in newborn babes and several benefits associated with them make it highly preferable. Benefits are short diagnostic period, low cost, easy collection & storage, minimally invasive procedure, high precision, and many more.

In addition, with the increasing incidences of HIV is also fueling market growth. Several players had launched technologically advanced cards for HIV testing and diagnosis. Some of them are Cobas Plasma Separation Cards launched by Roche.

Immediate Delivery Available | Buy this Premium Research Report@

https://www.visionresearchreports.com/report/cart/39702

Application Insights

The New Born Screening (NBS) segment dominated the market with a revenue share of over 20.3% in 2021. Increasing newborn screening is considered to be a significant growth factor in this market. For instance, according to the National Organization for Rare Disorders, it is estimated that around 4 million infants were screened in the U.S. in 2021 through drops of blood from the heel of the newborn prior to discharge from a hospital or birth center since the prevalence rate of certain metabolic errors, endocrinopathies, and hearing loss is high and can significantly contribute to morbidity.

Similarly, in May 2022, NHS England updated the guidance newborn blood spot (NBS) screening service for cystic fibrosis (CF) in the U.K. The guidance is considered a reference handbook for labs. The standard protocol includes IRT analysis based on an initial dried blood sample.

Similarly, the increasing use of dried blood spot collection card applications, such as forensic toxicology applications, compelled various players to innovate an efficient and cost-effective process. In research conducted by Simões et al. in August 2021, dried blood spot collection cards proved to be useful in detecting illicit drugs. The use of these cards also facilitates increased sample stability, allowing samples to be stored for a longer duration, thereby creating a safer work environment for analysts and sample collectors, as only a small sample volume is a requirement.

Card Type Insights

Whatman 903 held the largest revenue share of over 30.4% in 2021 as it is efficient and safe for sample identification, collection, and transport. Whatman paper is a specialized type of filter paper used extensively in qualitative analysis. The filter paper contains cellulose fibers and is manufactured using high-quality cotton linters. Thus, Whatman filter papers contain a higher proportion of alpha-cellulose, giving it consistency and quality. Growing usage of the Whatman card type in various research studies is another major factor expected to significantly impact market growth in the near future.

For instance, in June 2022, a group of researchers from the Division of Vector-Borne Diseases, Fort Collins, conducted a study to assess the Whatman FTA cards use in molecular diagnosis for detecting Yellow fever virus (YFV). The study conducted that the card can be easy to use and cost-effective in molecular diagnosis of yellow fever. Additionally, it enables the clinician to preserve viral RNA without a cold chain.

Furthermore, an increase in the utilization of Ahlstrom cards in various research studies focused on the diagnosis of diseases and other clinical applications is another major factor expected to propel the market growth during the forecast period. In March 2020, a research study published in Frontiers in Microbiology aimed at using dried blood spot tests for therapeutic monitoring and diagnosis of viral hepatitis B & C and HIV.

Regional Insights

North America dominated the market and held a revenue share of over 35.06% in 2021. The region is likely to continue a similar trend over the projected period. This growth can be attributed to the acceleration in government initiatives for newborn screening tests along with the growing research to expand the utility of DBS collection cards in various applications.

In the U.S., every baby born is required to be screened as a part of standard medical procedures, although the cost of newborn screening tests varies from state to state as each state's finance allocation is different. The screening expenses are reimbursed by health insurance or other programs. Hence, irrespective of healthcare insurance status, babies will receive the screening.

The Asia Pacific market is expected to register the fastest CAGR of 5.09% during the projected period. The key growth factors in the market are the presence of a large target population in countries, such as India, China, Japan, and South Korea. In addition, the growing adoption of innovative laboratory techniques and procedures such as dried blood spot collection cards for faster investigation and diagnosis of infectious and chronic disorders is one of the key factors driving the regional market.

Key Players

• QIAGEN
• Perkinelmer
• Roche
• Shimadzu Corporation
• Ahlstrom-Munksjö
• Pall Corporation
• Eastern Business Forms, Inc.
• Archimed Life Science GmbH
• Centogene N.V.

Market Segmentation

• By Application Outlook
  • New Born Screening (NBS)
  • Infectious Disease Testing
  • Therapeutic Drug Monitoring
  • Forensics
  • CRO/Research
  • Other Applications
• By Card Type Outlook
  • Whatman 903
  • Ahlstrom 226
  • FTA
  • Others
• By Regional Outlook
  • North America

• • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Immediate Delivery Available | Buy this Premium Research Report@

https://www.visionresearchreports.com/report/cart/39702

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://qyresearchmedical.com/